Translational lung cancer research
Utility of ctDNA-molecular residual disease in predicting minimal residual disease in non-small cell lung cancer patients after radical resection.
Katsuhiro Masago, Yoshitsugu Horio, Eiichi Sasaki, Shiro Fujita
Published: 202510.21037/tlcr-2025-470
No abstract available for this study.